放射性药品不良反应调查第41次报告(2018年第44次调查)。

Kaku igaku. The Japanese journal of nuclear medicine Pub Date : 2020-01-01 DOI:10.18893/kakuigaku.rp.2071

Hiroshi Matsuda, Tomoya Uehara, Hidehiko Okazawa, Sunao Mizumura, Kunihiko Yokoyama, Mana Yoshimura

{"title":"放射性药品不良反应调查第41次报告(2018年第44次调查)。","authors":"Hiroshi Matsuda, Tomoya Uehara, Hidehiko Okazawa, Sunao Mizumura, Kunihiko Yokoyama, Mana Yoshimura","doi":"10.18893/kakuigaku.rp.2071","DOIUrl":null,"url":null,"abstract":"This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].\",\"authors\":\"Hiroshi Matsuda, Tomoya Uehara, Hidehiko Okazawa, Sunao Mizumura, Kunihiko Yokoyama, Mana Yoshimura\",\"doi\":\"10.18893/kakuigaku.rp.2071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.\",\"PeriodicalId\":17738,\"journal\":{\"name\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18893/kakuigaku.rp.2071\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kaku igaku. The Japanese journal of nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18893/kakuigaku.rp.2071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本调查是为了调查日本2018财年放射性药物不良反应的发生率。该报告是根据对核医学机构的问卷调查得出的。在接获问卷的1,230所院校中，共有999所院校作出答复。报告不良反应14例。共报告了1,017,702例放射性药物管理。不良反应发生率为1.4 / 10万例。未发现缺陷产品。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Kaku igaku. The Japanese journal of nuclear medicine Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The main scope of JSNM is the appropriate development of the application of radioactive substances and stable nuclides in medicine. Towards this scope, JSNM promotes the exchange of idea and information, and researches in nuclear medicine. JSNM are interested in the international collaboration for the development of nuclear medicine. Through the activities, JSNM contributes to the medicine, as well as humanity, not only in Japan but also in any countries over the world.

期刊最新文献

[The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)].